TABLE OF CONTENTS
Volume 5, Issue 1 (2005)
In This Issue
Top of pageEELS (Ethical, Economic, Legal & Social) Article
Stored tissue samples: through the confidentiality maze FREE
Y Joly, B M Knoppers and M T Nguyen
Pharmacogenomics J 5: 2-5; doi:10.1038/sj.tpj.6500288
Review
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity FREE
M Ingelman-Sundberg
Pharmacogenomics J 5: 6-13; advance online publication, October 19, 2004; doi:10.1038/sj.tpj.6500285
Original Articles
Renin–angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients FREE
J Redon, M Luque-Otero, N Martell and F J Chaves on behalf of the POLPRI investigators
Pharmacogenomics J 5: 14-20; advance online publication, October 26, 2004; doi:10.1038/sj.tpj.6500280
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR FREE
G E Swan, A M Valdes, H Z Ring, T V Khroyan, L M Jack, C C Ton, S J Curry and T McAfee
Pharmacogenomics J 5: 21-29; advance online publication, October 19, 2004; doi:10.1038/sj.tpj.6500281
Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status FREE
S Almeida, N Franken, M R Zandoná, M C Osório-Wender and M H Hutz
Pharmacogenomics J 5: 30-34; advance online publication, September 21, 2004; doi:10.1038/sj.tpj.6500272
Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment FREE
A Dimitrova, V Milanova, S Krastev, I Nikolov, D Toncheva, M J Owen and G Kirov
Pharmacogenomics J 5: 35-41; advance online publication, October 26, 2004; doi:10.1038/sj.tpj.6500273
CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians FREE
G M Vasconcelos, C J Struchiner and G Suarez-Kurtz
Pharmacogenomics J 5: 42-48; advance online publication, November 9, 2004; doi:10.1038/sj.tpj.6500290
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression FREE
A Szegedi, D Rujescu, A Tadic, M J Müller, R Kohnen, H H Stassen and N Dahmen
Pharmacogenomics J 5: 49-53; advance online publication, November 2, 2004; doi:10.1038/sj.tpj.6500289
Interethnic variability of ERCC2 polymorphisms FREE
C R King, J Yu, R R Freimuth, H L McLeod and S Marsh
Pharmacogenomics J 5: 54-59; advance online publication, November 9, 2004; doi:10.1038/sj.tpj.6500283
Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism FREE
A K Tiwari, S N Deshpande, A R Rao, T Bhatia, S R Mukit, V Shriharsh, B Lerer, V L Nimagaonkar and B K Thelma
Pharmacogenomics J 5: 60-69; advance online publication, October 26, 2004; doi:10.1038/sj.tpj.6500282
